Prelude Capital Management’s Regulus Therapeutics RGLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-14,100
| Closed | -$25.2K | – | 1397 |
|
|
2024
Q2 | $25.2K | Sell |
14,100
-118,370
| -89% | -$211K | ﹤0.01% | 1076 |
|
|
2024
Q1 | $382K | Buy |
132,470
+92,210
| +229% | +$266K | 0.02% | 683 |
|
|
2023
Q4 | $51.5K | Hold |
40,260
| – | – | ﹤0.01% | 942 |
|
|
2023
Q3 | $55.2K | Sell |
40,260
-400
| -1% | -$548 | ﹤0.01% | 897 |
|
|
2023
Q2 | $59.8K | Buy |
+40,660
| New | +$59.8K | ﹤0.01% | 846 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 1402 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 1751 |
|
|
2016
Q2 | – | Sell |
-6
| Closed | -$5K | – | 1640 |
|
|
2016
Q1 | $5K | Buy |
+6
| New | +$5K | ﹤0.01% | 1119 |
|
|
2015
Q3 | – | Sell |
-2
| Closed | -$2K | – | 1641 |
|
|
2015
Q2 | $2K | Buy |
+2
| New | +$2K | ﹤0.01% | 1543 |
|